The heart has two upper chambers, the atria, and two lower chambers, the ventricles. Normally an electrical signal starts in the sinoatrial or sinus node in the right atrium. It spreads across the atria, passes through the atrioventricular (AV) node and travels through conducting pathways into the ventricles. This sequence coordinates filling and pumping; the electrical signal precedes the muscular contraction.

A rhythm disturbance, or arrhythmia, can make the heart beat too slowly, too quickly or irregularly. In ventricular tachycardia (VT), rapid signals arise in the ventricles. A very fast rhythm may leave too little time for the chambers to fill and reduce blood reaching the brain and body. Symptoms can include palpitations, dizziness, chest pain, breathlessness or fainting, but symptoms alone cannot identify the rhythm.

In ventricular fibrillation (VF), electrical activity is chaotic and the ventricles quiver instead of pumping effectively. This causes cardiac arrest: the person becomes unresponsive and is not breathing normally. A heart attack is different: it usually involves a blocked blood supply to heart muscle, and may trigger cardiac arrest. An ICD is intended to recognise and treat selected dangerous ventricular rhythms, not every possible cause of collapse.

An ICD is a battery-powered electronic device placed under the skin. It monitors the heart rhythm and is programmed to respond to particular fast ventricular rhythms. A transvenous ICD connects to leads positioned through a vein in the heart. Other designs use an electrode under the skin outside the ribcage. The generator contains the battery, electronics and stored rhythm information.

Some transvenous ICDs can deliver a brief run of rapid, low-energy pulses called anti-tachycardia pacing (ATP), which may stop some VT without a shock. If a rhythm is very fast or persists, the ICD may deliver a shock. Which treatments are enabled and when they are delivered depend on device type and programming. A shock can feel like a sudden thump or kick and can be painful or frightening.

A conventional pacemaker mainly treats an abnormally slow heart rhythm by delivering pacing impulses; it does not provide the high-energy defibrillation therapy of an ICD. Many transvenous ICDs can also provide slow-rate pacing, but not every ICD has the same pacing capabilities. A cardiac resynchronisation device with a defibrillator, CRT-D, combines coordination of the ventricles with ICD shock capability. Ask which functions your proposed device has.

An ICD can reduce risk from some life-threatening rhythms, but it does not cure the underlying heart condition or guarantee survival from cardiac arrest. It will not treat every rhythm or every reason for a collapse. Monitoring, medicines and treatment of the underlying heart condition remain important. Never stop or change prescribed medicines without discussing them with your team.

Secondary prevention means an ICD is considered after a serious ventricular rhythm has already occurred, such as survival of a cardiac arrest caused by VT or VF, or certain sustained VT episodes. NICE specifies circumstances in which an ICD is an option when the serious rhythm was not due to a treatable cause. The team should explain what happened during your episode and whether a reversible cause has been identified and addressed.

Primary prevention means considering an ICD before a cardiac arrest or qualifying serious ventricular rhythm has occurred, because assessment suggests a high risk. Circumstances can include some inherited heart conditions, cardiomyopathy or impaired left ventricular pumping. Many people with these conditions will not need an ICD. The recommendation depends on the diagnosis, test results and the expected benefit and burden for that individual.

An echocardiogram estimates left ventricular ejection fraction (LVEF), the proportion of blood in the left ventricle pumped out with a beat. ECG findings such as QRS width and whether left bundle branch block is present help assess electrical conduction. NICE TA314 uses LVEF, symptom class and ECG features to identify different ICD, CRT-D and CRT-P options in heart failure with LVEF of 35% or less. One measurement by itself does not decide which device is right for you.

An ECG or rhythm monitor can document the electrical pattern; an echocardiogram shows heart structure and pumping. Depending on the question, the team may suggest further imaging or an electrophysiology study. If an inherited condition is suspected, the team may discuss genetic assessment and whether relatives need evaluation. Ask how certain the diagnosis is and what risk the proposed ICD is intended to reduce.

A transvenous ICD usually sits below the collarbone. One or more leads pass through a vein into the heart. This route allows sensing, shock delivery and, depending on the device, slow-rate pacing or ATP. It also creates risks associated with a lead inside the heart and vein, including lead movement, infection and later lead malfunction or a need for another procedure.

A subcutaneous ICD, or S-ICD, has a generator at the side of the chest and an electrode placed beneath the skin; no lead enters the heart or veins. The design avoids transvenous lead-related problems but still has surgical, infection and inappropriate-shock risks. The conventional S-ICD used in the PRAETORIAN trial did not provide ongoing slow-rate pacing, CRT or ATP, making it unsuitable when those functions are needed. Ask which system is available locally and what it can do.

CRT helps coordinate contraction of the ventricles in selected people with heart failure and electrical conduction delay. CRT-D adds defibrillation; CRT-P provides resynchronisation pacing without defibrillator shocks. NICE uses different combinations of heart failure symptoms and ECG findings when considering these options. The choice is about both pumping support and the value and burden of shock treatment for your situation.

In the PRAETORIAN randomised trial, 849 adults who needed an ICD but did not need pacing were assigned subcutaneous or transvenous devices. At about four years the subcutaneous device met the trial’s non-inferiority criterion for a combined outcome of device-related complications and inappropriate shocks. This is not proof that every individual complication or the two devices were identical. The trial excluded people needing pacing or CRT and some people with recurrent VT for whom ATP was especially important; the results cannot be applied automatically to them. The manufacturer funded the study.

Depending on the diagnosis, treatment can include medicines, correction of a treatable trigger, treatment for heart failure, cardioversion or catheter ablation. Ablation uses a catheter to target tissue involved in an abnormal rhythm. It may reduce arrhythmia episodes in selected people, but it is not automatically an equivalent replacement for an ICD in a person at risk of a life-threatening ventricular rhythm. These treatments may be used alongside an ICD.

If the recommendation is for primary prevention, ask whether further treatment or reassessment of heart function is appropriate before a decision, and what protection and monitoring apply while waiting. If an ICD is recommended after a serious arrhythmia, ask what the team believes will happen without it. Waiting, declining implantation or choosing comfort-focused care are decisions to discuss openly, with the likely consequences and a clear plan for symptoms and emergencies.

An informed choice considers the chance of benefit alongside procedure risks, later lead or battery procedures, possible shocks, driving restrictions and your priorities. You can ask for the information in a different format, bring someone to the conversation and, when time allows, take time to decide. You can change your mind before treatment; an emergency can alter how much time is available.

The DANISH trial randomly assigned 1,116 adults with symptomatic non-ischaemic systolic heart failure and LVEF of 35% or less to an ICD or usual care. At a median 67.6 months, deaths from any cause were 120 of 556 in the ICD group and 131 of 560 in the control group; the difference was not statistically significant. Sudden cardiac deaths were 24 of 556 and 46 of 560 respectively. A reduction in sudden cardiac death and a proven reduction in all-cause mortality are different outcomes.

In DANISH, 58% of each group also received CRT, and the trial was unblinded. It studied a defined group with non-ischaemic heart failure, not all ICD recipients or people who had already survived a serious ventricular arrhythmia. The investigator-initiated trial received funding from device manufacturers and charities. Treatment has changed since the trial. The findings do not prove that an ICD never improves overall survival in any person, or predict an individual outcome. Ask the team which evidence best matches your diagnosis and current treatment.

At pre-assessment, discuss your diagnosis, the proposed device and side of implantation, other illnesses, allergies and any previous surgery or devices. Bring an up-to-date list of prescribed medicines, over-the-counter medicines, vitamins and supplements. Tell the team if pregnancy is possible because X-rays may be used during a transvenous implant. Ask what support you might need at home and arrange your journey home.

Follow your own hospital’s instructions about fasting and medicines. The plan can be different for anticoagulants, antiplatelets and diabetes treatment, so ask for specific written instructions. Do not stop or change prescribed medicines on your own. If you develop an infection, fever or a new illness before the procedure, tell the team and ask whether the plan needs to change.

Before giving consent, ask about the expected benefit for you, the alternatives and the risks of both having and not having the implant. Discuss your work, driving, sport and any questions about shocks or future procedures. Ask for an explanation or more time if you need it; consent remains your choice.

For a typical transvenous ICD implant, the team cleans the skin, places a small cannula in a vein and gives antibiotics and, if appropriate, sedation and pain relief. Local anaesthetic numbs the implant area, usually beneath the collarbone. You may be awake but relaxed; tell the team if anything hurts. The exact anaesthetic and procedure can differ with the device and your circumstances.

A clinician makes a small cut and creates a pocket for the generator. One or more leads are passed through a vein into the heart with X-ray guidance, then checked, secured and connected to the generator. The wound is closed and covered. Dorset’s leaflet gives a usual procedure time of one to two hours for its transvenous implant, but this is not a promise for every procedure. An S-ICD is placed under the skin at the side of the chest with its electrode under the skin of the chest, rather than in a vein or the heart.

After implantation the team checks the wound and device, and may use a chest X-ray to check the leads and lungs. Some people go home the same day; others need to stay longer, depending on the device, recovery and reason for treatment. Before discharge, ask for your device details, emergency contacts, wound-care instructions and follow-up plan.

Bleeding, bruising and soreness around the pocket can occur. Infection can affect the wound or the device system and may require antibiotics and further treatment. A lead may move and need repositioning. Rarely, during transvenous lead placement, a lung can be punctured and air collect around it, or the heart wall can be punctured with fluid collecting around the heart. These complications can require urgent treatment or another procedure.

An ICD may deliver an inappropriate shock, for example when a rhythm or electrical signal is incorrectly interpreted. A shock can be painful and distressing whether appropriate or inappropriate. A clinician can review the recorded rhythm and may adjust programming or treatment to reduce further shocks. The device or a lead can also develop a fault over time. Ask about the risks most relevant to your proposed system and how the team responds to them.

Later procedures may be needed for battery replacement, a lead problem or infection. Lead extraction is a separate, more complex procedure than changing a generator and carries its own risks; ask why it is being recommended and where it would be performed. The balance of benefits and harms is individual and can change with age, heart function, other illnesses and your priorities.

The implant area may be sore or stiff for several weeks. Follow your discharge instructions about pain relief, dressings, showering and keeping the wound dry. Wound-care advice differs between hospitals, so use the instructions for your own dressing rather than a generic timetable. Do not move or manipulate the generator under the skin.

For a new transvenous lead, your team may limit lifting and movement of the arm on the implant side while the lead settles. Dorset advises avoiding lifting that arm above shoulder height and heavy pushing or lifting for about four weeks, alongside gentle arm movement to prevent stiffness. Cambridge uses a different early schedule. Ask your own team exactly what applies to your implant, your work and your shoulder, and when to restart exercise, lifting, sport and sex.

Contact your device team promptly if the wound becomes more red, hot, swollen, painful or starts oozing, or if you develop a fever. Wound infection or skin breakdown can occur months or years later too. New shoulder twitching or persistent hiccups should be reported to the device team. A blackout, severe breathlessness or severe chest pain needs urgent assessment: follow the emergency instructions at the start of this guide.

Anxiety about shocks, changes in independence or the reason for implantation is common. Tell your heart team if fear affects sleep, work or relationships. Ask about cardiac rehabilitation, psychological support or a patient support group. Return to activity gradually as advised for both your implant and your underlying heart condition.

You may feel palpitations or dizziness before a shock, or no warning at all. If you feel unwell, sit or lie down and alert someone. More than one shock, or one shock followed by feeling unwell, means call 999. If you have one shock and feel well afterwards, contact the ICD clinic as soon as possible and use its out-of-hours instructions. Do not drive until assessed and the applicable driving rules are clear.

The device records information that helps the team determine what rhythm occurred and whether treatment was appropriate. You cannot reliably judge that from the sensation alone. Tell the team when the shock happened, what you were doing and how you felt before and afterwards. If you hear an alarm or feel a vibration from the device, contact your device team for advice because a check is needed to find the cause.

If another person is touching you when the ICD delivers a shock, they may feel movement or a tingle but will not receive the full shock. If someone is unresponsive and not breathing normally, a bystander should call 999, start CPR and use an AED as directed, even if the person has an ICD.

Regular checks review stored heart rhythms and therapies, lead measurements, settings and the estimated remaining battery life. Follow-up may combine clinic visits with a home monitor, and the schedule depends on the device and your needs. Ask how to set up the monitor, what information it sends, whether it is checked continuously, and what to do if it disconnects. Remote monitoring does not replace calling 999 for an emergency or contacting the team about symptoms.

Battery life depends on the model and use. Dorset gives an approximate range of five to ten years for ICDs in its service. The battery is sealed in the generator, so when it approaches replacement the whole generator is changed. Existing leads are often retained if they work well, although this decision is individual. A generator change is another opportunity to review the likely benefit and burden of ongoing ICD therapy.

Keep your device identification card with you and show it to healthcare professionals. Know the name and phone number of your device clinic, including the out-of-hours contact. Ask what to do if you miss a check, change address or need care away from your usual hospital.

In Great Britain you must notify DVLA that an ICD has been fitted and tell your insurer. For Group 1 car and motorcycle licences, DVLA guidance says an asymptomatic person receiving a primary-prevention ICD must stop driving for one month after implantation and may resume only if they remain asymptomatic and have needed no ICD therapy, with no other disqualifying condition. For an ICD implanted after sustained ventricular arrhythmia, the usual restriction is six months after implantation, subject to the stated conditions. Your clinical situation can add further restrictions.

After shock therapy, or anti-tachycardia pacing associated with or likely to cause incapacity, the rule depends on the cause. For appropriate therapy for sustained VT or VF, DVLA specifies six months after the most recent qualifying therapy and notification. For inappropriate therapy, driving may resume one month after its cause is completely controlled to the cardiologist’s satisfaction, with other conditions met. Do not decide for yourself which category applies: stop driving after a shock and get the device team’s assessment and current licensing advice.

For Great Britain, an implanted ICD is a permanent bar to Group 2 bus and lorry licensing and DVLA must be notified. In Northern Ireland the Driver & Vehicle Agency (DVA) is the licensing authority, and NI Direct says you must tell DVA about an implanted defibrillator. Ask your team and the appropriate authority for the current rules for your licence, diagnosis and any treatment, and check insurance before returning to driving.

Most well-maintained household and office electrical equipment, including microwave ovens, can be used. Strong magnets and some industrial equipment may interfere with an ICD. Keep a mobile phone about 15 cm from the device, use the opposite ear and avoid carrying it in a pocket over the implant. Ask your device team about your specific model, induction hob, power tools, workplace equipment or any other source you are concerned about.

Tell doctors, dentists, radiographers, surgeons and other healthcare staff that you have an ICD before tests or treatment. MRI is possible for some people with some systems under specific conditions, but the device and leads need checking and a plan before the scan. Electrocautery, radiotherapy and TENS can require precautions or specialist advice. Do not assume a procedure is safe or unsafe for your particular device without checking.

Ask your team when it is safe for you to travel, because advice differs with your recovery and underlying condition. Carry your device card, disclose the ICD to your travel insurer and tell airport security about it. Walk through shop security gates without lingering. Discuss contact sports, physically demanding work and activities in which a sudden loss of consciousness could be especially dangerous; the device and your diagnosis both matter.

Your wishes may change if your health changes, including near the end of life. The shock function can be turned off by a trained professional using a programmer; this is normally a planned discussion with you and your care team. If you later change your mind, it can be turned on again when appropriate. Turning off shocks does not itself cause immediate death, but a future dangerous rhythm would not receive an ICD shock.

An ICD may also have pacing functions. Ask exactly which therapies would be changed, whether any pacing needed for a slow rhythm would continue, and how the decision relates to your goals and emergency care plan. You can discuss and record your wishes with your cardiology and wider care team before a crisis.